Management of catatonic stupor with L-dopa.
D014150:Antipsychotic Agents / Q000009:adverse effects; D002389:Catatonia / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy / Q000523:psychology
D014150:Antipsychotic Agents; D007980:Levodopa